JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasanna, G.
Right arrow Articles by Yorio, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasanna, G.
Right arrow Articles by Yorio, T.

Vol. 296, Issue 3, 966-971, March 2001

Inhibition of Na+/K+-ATPase by Endothelin-1 in Human Nonpigmented Ciliary Epithelial Cells

Ganesh Prasanna, Adnan Dibas, Christina Hulet and Thomas Yorio

Department of Pharmacology, University of North Texas Health Science Center, Fort Worth, Texas (G.P., C.H., T.Y.); and Department of Immunology, St. Paul Medical Center, Mary Kay Ash Institute for Cancer Research, Dallas, Texas (A.D.)

Endothelin-1 (ET-1), a potent vasoconstrictor, lowers intraocular pressure in mammals, either by enhancing the outflow of aqueous humor (AH) via the trabecular meshwork and Schlemm's canal or by reducing AH formation at the ciliary epithelium. Aqueous humor production occurs by passive diffusion of water coupled with active transport of ions, mainly involving Na+:K+:2Cl- cotransporter and Na+/K+-ATPase pump from serosal to aqueous side. Presently, we have evaluated the effects of ET-1 on Na+:K+:2Cl- cotransport and Na+/K+-ATPase activity in HNPE cells using 86Rb+ uptake. ET-1 (100 pM-100 nM) decreased mean 86Rb+ uptake by 15% during a 15-min uptake period. ET-1's effect was not prevented by BQ610, an ETA receptor antagonist, but was blocked by BQ788, an ETB receptor antagonist. ET-1's effect was mimicked by sarafotoxin, an ETB agonist. ET-1-induced reduction in 86Rb+ uptake was additive with bumetanide, a selective inhibitor of Na+:K+:2Cl- cotransporter but not with ouabain, a selective inhibitor of the Na+/K+-ATPase. ET-1 did not affect iberiotoxin-sensitive maxi K+ channels. This suggests that ET-1-induced reduction in 86Rb+ uptake is mediated through the inhibition of the Na+/K+-ATPase via an ETB-like receptor. These findings are consistent with an ET-1 effect on active ion transport activity in HNPE cells that could explain the reduction in aqueous humor production and the lowering of intraocular pressure.


0022-3565/01/2963-0966$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.